SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is under pressure amid a broader selloff in AI data-center stocks, with traders concerned that Democratic gains could bring tighter permitting and slow Texas projects; a report tying IREN delays to Microsofts lower data-center spending has added to execution worries ahead of earnings. The discussion is largely bearish, though some traders argue existing power assets and approvals may limit the impact of future restrictions.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

A sharp post-earnings selloff despite a strong results-and-guidance beat has traders debating whether margin pressure and heavy reliance on one large customer outweigh SMCIs AI-server growth. Some also blame election-related fears of slower data-center expansion, while bullish traders view the drop as disconnected from the companys outlook.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron is caught in a broader semiconductor and AI-stock selloff as traders worry that Democratic gains and calls for tighter AI oversight could slow data-center expansion and weaken future memory demand. The community is split between bearish views that AI spending and the memory cycle are peaking and bullish arguments that strong demand and company fundamentals make the pullback an overreaction.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Concerns that a Democratic sweep and calls for tighter AI oversight could slow future data-center construction are weighing on Sandisk alongside a sharp selloff in memory and semiconductor stocks. Traders are split between expecting further downside as AI infrastructure demand and memory pricing face risks, and viewing the drop as excessive given the companys earnings and memory-demand outlook.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Fears that Democratic control of Congress could bring tighter AI and data-center rules or delay buildouts are weighing on Nvidia and other semiconductor stocks, alongside concerns about AI spending and circular financing. Traders are divided between viewing the selloff as an overreaction and warning that the AI trade is breaking down.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

Fears that Democratic gains could bring tighter regulation or delays for AI data centers are weighing on semiconductor stocks, with SOXLs 3x leverage amplifying the sectors sharp selloff. Traders debate whether the AI-buildout concerns justify further downside or are an overreaction, as some see lasting chip demand and a potential rebound while others warn of continued weakness.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is being swept up in a semiconductor and AI-stock selloff as traders question whether massive data-center spending can generate adequate returns and worry about financing and customer concentration. Bears see risks to custom-chip demand if hyperscalers pull back, while bulls argue Broadcom benefits from their continued investment and that the decline reflects sector-wide selling rather than company-specific weakness.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras steep post-IPO selloff has traders focused on a short-seller report questioning wafer-chip durability, the technology and the OpenAI relationship, alongside concerns about an upcoming share unlock and earnings. Bulls argue the stock is oversold and defend its AI business prospects, while bears expect further pressure and question its valuation.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvells proposed all-stock acquisition of Lumentum is dominating discussion amid a sharp selloff, with traders questioning the deals valuation, dilution and lengthy approval timeline while others argue the combination strengthens Marvells AI-data-center and optical-networking position. Broader semiconductor weakness and concerns about data-center expansion are adding to bearish sentiment.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X ETF

SOXS is drawing attention as traders use the inverse semiconductor ETF to trade a sharp chip-sector selloff, with many linking the weakness to midterm results and concerns about potential AI and data-center policy changes. Some expect further downside in semiconductors, while others anticipate a relief rally and warn that SOXSs daily leverage makes it risky to hold through volatile reversals.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SOPHiA GENETICS SA (SOPH) Reports Q3 Loss, Beats Revenue Estimates

SOPHiA GENETICS (SOPH) delivered earnings and revenue surprises of -84.62% and +1.58%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

SOPHiA GENETICS Reports Third Quarter 2026 Results

SOPHiA GENETICS Reports Third Quarter 2026 Results SOPHiA GENETICS Reports Third Quarter 2026 ResultsPR NewswireBOSTON and ROLLE, Switzerland, Nov. 3, 2026 BOSTON andROLLE, Switzerland, Nov. 3, 2026 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine...

SOPHiA GENETICS to Announce Financial Results for Third Quarter 2026 on November 3, 2026

SOPHiA GENETICS to Announce Financial Results for Third Quarter 2026 on November 3, 2026 SOPHiA GENETICS to Announce Financial Results for Third Quarter 2026 on November 3, 2026PR NewswireBOSTON and ROLLE, Switzerland, Oct. 20, 2026BOSTON and ROLLE, Switzerland, Oct. 20, 2026 /PRNewswire/ -- SOPHiA...

SOPHiA GENETICS and Myriad Genetics Announce New Collaboration to Advance Prostate Genomic Instability Score Technology

SOPHiA GENETICS and Myriad Genetics Announce New Collaboration to Advance Prostate Genomic Instability Score Technology SOPHiA GENETICS and Myriad Genetics Announce New Collaboration to Advance Prostate Genomic Instability Score TechnologyPR NewswireBOSTON, Oct. 8, 2026BOSTON, Oct. 8, 2026...

SOPHiA GENETICS (SOPH) Moves 7.0% Higher: Will This Strength Last?

SOPHiA GENETICS (SOPH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

SOPH Stock Heads For Best Day In Over 8 Months – What’s Driving Today’s Super Rally?

Equity

Sophia Genetics announced a partnership with AstraZeneca to develop two cancer diagnostic tests and also raised its full-year revenue forecast.

SOPHiA GENETICS Reports Second Quarter 2026 Results

SOPHiA GENETICS Reports Second Quarter 2026 Results SOPHiA GENETICS Reports Second Quarter 2026 Results PR Newswire BOSTON and ROLLE, Switzerland, Aug. 4, 2026 BOSTON andROLLE, Switzerland, Aug. 4, 2026 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine...

SOPHiA GENETICS Enters Collaboration to Develop Companion Diagnostics for Precision Oncology Therapies

SOPHiA GENETICS Enters Collaboration to Develop Companion Diagnostics for Precision Oncology Therapies SOPHiA GENETICS Enters Collaboration to Develop Companion Diagnostics for Precision Oncology Therapies PR Newswire BOSTON and ROLLE, Switzerland, Aug. 4, 2026 BOSTON and ROLLE, Switzerland, Aug...

Tempus AI Stock Before Q2 Earnings Release: To Buy, Hold or Sell?

TEM heads into Q2 earnings with 21.3% expected revenue growth, strong diagnostics demand and AI deals, but near-term margin pressure remains.

SOPHiA GENETICS to Announce Financial Results for Second Quarter 2026 on August 4, 2026

SOPHiA GENETICS to Announce Financial Results for Second Quarter 2026 on August 4, 2026 SOPHiA GENETICS to Announce Financial Results for Second Quarter 2026 on August 4, 2026 PR Newswire BOSTON and ROLLE, Switzerland, July 21, 2026 BOSTON and ROLLE, Switzerland, July 21, 2026 /PRNewswire...

$SOPH Q3 &#39;26 Earnings Results &amp; Recap

• Reported GAAP EPS of -$0.24 up 20.00% YoY
• Reported revenue of $24.27M up 24.72% YoY
• SOPHiA GENETICS expects FY 2026 revenue at the upper end of its previously issued $94M to $96M range and adjusted EBITDA loss between $29M and $32M.

Stocktwits

SOPHiA Genetics SA

 Q3 '26 Earnings Results & Recap

• Reported GAAP EPS of -$0.24 up 20.00% YoY
• Reported revenue of $24.27M up 24.72% YoY
• SOPHiA GENETICS expects FY 2026 revenue at the upper end of its previously issued $94M to $96M range and adjusted EBITDA loss between $29M and $32M.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

• Reported GAAP EPS of -$0.24 up 20.00% YoY
• Reported revenue of $24.27M up 24.72% YoY
• SOPHiA GENETICS expects FY 2026 revenue at the upper end of its previously issued $94M to $96M range and adjusted EBITDA loss between $29M and $32M.

SOPHiA GENETICS reported lower gross-margin comparisons, warned sustained foreign-exchange movements could weigh on fourth-quarter revenue, and disclosed litigation expenses tied to Guardant Health lawsuits that may increase.

SOPHiA GENETICS expanded analysis volume and its genomics customer base, added new BioPharma collaborations and companion-diagnostic programs, and reduced adjusted EBITDA loss while reaffirming a 2027 profitability target.

SOPHiA GENETICS SA is a healthcare technology company, which engages in the practice of data driven medicine as the standard of care and for life sciences research. It operates through the following geographical segments: France, Italy, United States, Spain, Turkey, Austria, Brazil, United Kingdom, Switzerland, Germany, and Other. It is the creator of the SOPHiA DDM Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The company was founded by Jurgi Camblong, Pierre Hutter and Lars Steinmetz in 2011 and is headquartered in Saint Sulpice, Switzerland.

Bullish Sentiment

<ul class="summary-bullets"><li>Sophia Genetics will develop one diagnostic test for solid tumors and another for blood cancer.</li><li>The firm raised its full-year 2026 revenue guidance to $94 million to $96 million, up from $92 million to $94 million.</li><li>The company reported second-quarter revenue of $23.3 million, ahead of Wall Street estimates of $21.7 million, according to Fiscal.ai data.</li></ul>Shares of Sophia Genetics (SOPH) surged nearly 16% on Tuesday after the company announced a collaboration with AstraZeneca (AZN) to develop two companion diagnostic tests for precision cancer therapies and raised its full-year revenue guidance following stronger-than-expected second-quarter sales.<a href="https://stocktwits.com/symbol/SOPH">SOPH stock</a> has clocked its biggest single-day gains since November 2025.<h2 class="st-heading-2">Sophia Genetics To Develop Diagnostic Tests For Solid Tumors And Blood Cancer</h2>Under the multi-year agreement, Sophia Genetics will develop, validate and commercialize two companion diagnostic programs to support AstraZeneca’s precision oncology treatments.A companion diagnostic test helps doctors decide whether a patient is likely to benefit from a specific drug. It can also identify patients at higher risk of side effects and help monitor how well the treatment is working.Sophia Genetics will develop one diagnostic test for solid tumors and another for blood cancer. The company aims to speed up access to new treatments by identifying the right patients.<h2 class="st-heading-2">SOPH Raises FY26 Revenue Forecast</h2>The company reported second-quarter revenue of $23.3 million, up 27% from a year earlier and ahead of Wall Street estimates of $21.7 million, according to Fiscal.ai data.&nbsp;However, it posted a loss of $0.30 per share, wider than analysts' expectations for a $0.22 per-share loss.“Strong revenue performance was driven by 60% volume growth in the U.S., 70% volume growth in Liquid Biopsy, and accelerating growth in BioPharma,” said CEO Ross Muken.Sophia Genetics also raised its full-year 2026 revenue guidance to $94 million to $96 million, up from its previous forecast of $92 million to $94 million. The updated forecast represents annual growth of 22% to 24%.<h2 class="st-heading-2">Retail Turns Bullish On SOPH</h2>Retail sentiment surrounding SOPH on Stocktwits turned ‘bullish’ from ‘neutral’ over the past 24 hours.The stock has gained around 41% so far this year.Also read:&nbsp; <a href="https://stocktwits.com/news-articles/markets/equity/intuitive-machines-expands-defense-footprint-with-missile-tracking-deal-retail-eyes-upside-/cZo5NO7RJEr">Intuitive Machines Expands Defense Footprint With Missile Tracking Deal – Retail Eyes 50% Upside For LUNR Stock Due To ‘Big News’</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Current Price	$6.97
Prev Close	$6.91
Open	$6.99
Dividend Yield	0.00%
50-Day Moving Average	$7.78
Beta	1.00
Avg. Volume	573,279.13
PE Ratio	-6.38

52-Week High	$8.98
52-Week Low	$3.83
Market Capitalization	$588.23M
EPS (Annual)	-$1.17
Price to Book	8.73
Revenue Per Employee	$186,195.18

Feed

News

Sentiment

Earnings

Fundamentals

Info

SOPH Fundamentals